Currently, out of the existing stock ratings of Jami Rubin - 43 which are a Buy (46.24%), 32 which are a Hold (34.41%), 18 which are a Sell (19.35%)

Jami Rubin

Work Performance Price Targets & Ratings Chart

Analyst Jami Rubin was covering the Healthcare sector with 186 price targets and ratings displayed on 13 stocks. Previously, Jami Rubin worked at GOLDMAN SACHS.

Jami Rubin's average stock forecast success ratio is 79.49% with an average time for price targets to be met of 449.31 days.

Most recent stock forecast was given on TEVA, Teva Pharmaceutical Industries at 01-Oct-2018.

Wall Street Analyst Jami Rubin

Analyst best performing recommendations are on PRGO (PERRIGO COMPANY PLC).
The best stock recommendation documented was for PRGO (PERRIGO COMPANY PLC) at 1/30/2017. The price target of $75 was fulfilled within 16 days with a profit of $8.52 (12.82%) receiving and performance score of 8.01.

Average potential price target upside

of $32.04 (62.97%) on ABBV (ABBVIE).
of $19.55 (54.96%) on BMY (BRISTOLMYERS SQUIBB COMPANY).
of $19.14 (20.8%) on JNJ (JOHNSON & JOHNSON).

ABBV AbbVie AGN BMY BristolMyers Squibb Company JNJ Johnson & Johnson MRK Merck . MYL PRGO Perrigo Company plc TEVA Teva Pharmaceutical Industries LLY Eli Lilly and Company PFE Pfizer VTRS ALNY Alnylam Pharmaceuticals ZTS Zoetis

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Christopher Raymond (PIPER SANDLER)